Literature DB >> 8883400

Up-regulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx.

S Parolini1, D Flagiello, A Cinquetti, R Gozzi, S Cristini, J Cappiello, P Nicolai, M Rusnati, M Presta, M M Tosatti.   

Abstract

The expression of urokinase-type plasminogen activator (uPA) was investigated in squamous cell carcinoma of the human larynx. For this purpose, tissue extracts from 25 matched samples of normal mucosa and neoplastic larynx were compared for the levels of uPA activity as evaluated by a chromogenic PA assay and sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) zymography. Also, uPA antigen was quantified by enzyme-linked immunosorbent assay (ELISA) in 19 cases. The results demonstrate a significant increase in the levels of uPA activity and protein in tumour tissue extracts, more pronounced in tumours with lymph node metastases. Immunohistochemistry performed on 70 biopsies showed that uPA positivity is present both in neoplastic cells and in fibroblast-like cells and macrophages. However, depending on the histological grading and invasive capacity of the tumour, a pronounced intra- and intertumoral heterogeneity in uPA staining was observed. In situ hybridisation confirmed the presence of uPA mRNA in both tumour and stromal cells. The present study provides experimental evidence for a role of uPA in the invasive growth of human laryngeal carcinoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8883400      PMCID: PMC2075918          DOI: 10.1038/bjc.1996.512

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  45 in total

Review 1.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

2.  Molecular species of plasminogen activators secreted by normal and neoplastic human cells.

Authors:  E L Wilson; M L Becker; E G Hoal; E B Dowdle
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

3.  Relationship between multiple forms of plasminogen activator in human breast tumors and plasma and the presence of metastases in lymph nodes.

Authors:  M Colombi; S Barlati; H Magdelenat; B Fiszer-Szafarz
Journal:  Cancer Res       Date:  1984-07       Impact factor: 12.701

4.  Content and characterization of plasminogen activators in human lung tumors and normal lung tissue.

Authors:  G Markus; H Takita; S M Camiolo; J G Corasanti; J L Evers; G H Hobika
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

5.  Plasminogen activator content of neoplastic and benign human prostate tissues; fibrin augmentation of an activator activity.

Authors:  S M Camiolo; G Markus; J L Evers; G H Hobika; J L DePasquale; S Beckley; J P Grimaldi
Journal:  Int J Cancer       Date:  1981-02-15       Impact factor: 7.396

6.  Antibodies to plasminogen activator inhibit human tumor metastasis.

Authors:  L Ossowski; E Reich
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

7.  Plasminogen activator activity in human endometrial carcinoma.

Authors:  C W Whitney; P G Satyaswaroop; R Mortel
Journal:  Gynecol Oncol       Date:  1985-09       Impact factor: 5.482

8.  Plasminogen activator content and secretion in explants of neoplastic and benign human prostate tissues.

Authors:  S M Camiolo; G Markus; L S Englander; M R Siuta; G H Hobika; S Kohga
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

9.  Localization of plasminogen activators in human colon cancer by immunoperoxidase staining.

Authors:  S Kohga; S R Harvey; R M Weaver; G Markus
Journal:  Cancer Res       Date:  1985-04       Impact factor: 12.701

10.  Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma.

Authors:  L Skriver; L I Larsson; V Kielberg; L S Nielsen; P B Andresen; P Kristensen; K Danø
Journal:  J Cell Biol       Date:  1984-08       Impact factor: 10.539

View more
  1 in total

1.  Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.

Authors:  Lusia Sepiashvili; Angela Hui; Vladimir Ignatchenko; Willa Shi; Susie Su; Wei Xu; Shao Hui Huang; Brian O'Sullivan; John Waldron; Jonathan C Irish; Bayardo Perez-Ordonez; Fei-Fei Liu; Thomas Kislinger
Journal:  Mol Cell Proteomics       Date:  2012-08-23       Impact factor: 5.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.